{"news_desk": "Letters", "print_page": "34", "section_name": "Opinion", "subsection_name": null, "byline": [], "abstract": null, "type_of_material": "Letter", "word_count": "222", "lead_paragraph": "The pharmaceutical trade group writes that F.D.A. policies should include sharing more information about the evolving use of medicines.", "pub_date": "2015-11-11T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Adult Drugs for Children", "content_kicker": "Letter", "print_headline": "Adult Drugs for Children", "kicker": "Letter"}, "snippet": "The pharmaceutical trade group writes that F.D.A. policies should include sharing more information about the evolving use of medicines.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/11/11/opinion/adult-drugs-for-children.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Children and Childhood", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}], "blog": [], "_id": "5642fa7538f0d842ce0a8981", "source": "The New York Times"}